{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,8]],"date-time":"2026-02-08T08:41:11Z","timestamp":1770540071238,"version":"3.49.0"},"reference-count":81,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T00:00:00Z","timestamp":1591920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s10822-020-00321-1","type":"journal-article","created":{"date-parts":[[2020,6,12]],"date-time":"2020-06-12T04:28:22Z","timestamp":1591936102000},"page":"541-555","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":16,"title":["Predicting reactivity to drug metabolism: beyond P450s\u2014modelling FMOs and UGTs"],"prefix":"10.1007","volume":"35","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4292-5557","authenticated-orcid":false,"given":"Mario","family":"\u00d6eren","sequence":"first","affiliation":[]},{"given":"Peter J.","family":"Walton","sequence":"additional","affiliation":[]},{"given":"Peter A.","family":"Hunt","sequence":"additional","affiliation":[]},{"given":"David J.","family":"Ponting","sequence":"additional","affiliation":[]},{"given":"Matthew D.","family":"Segall","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2020,6,12]]},"reference":[{"key":"321_CR1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/BF02977789","volume":"28","author":"C Xu","year":"2005","unstructured":"Xu C, Li CY-T, Kong A-NT (2005) Induction of phase I, II and III drug metabolism\/transport by xenobiotics. Arch Pharm Res 28:249\u2013268","journal-title":"Arch Pharm Res"},{"issue":"5","key":"321_CR2","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1097\/00004714-200110000-00008","volume":"21","author":"HL Liston","year":"2001","unstructured":"Liston HL, Markowitz JS, DeVane CL (2001) Drug glucuronidation in clinical psychopharmacology. J Clin Psychopharmacol 21(5):500\u2013515","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"321_CR3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0163-7258(91)90065-T","volume":"51","author":"JO Miners","year":"1991","unstructured":"Miners JO, Mackenzie PI (1991) Drug glucuronidation in humans. Pharmacol Ther 51(3):347\u2013369","journal-title":"Pharmacol Ther"},{"issue":"1","key":"321_CR4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1146\/annurev.pharmtox.44.101802.121546","volume":"44","author":"JO Miners","year":"2004","unstructured":"Miners JO, Smith PA, Sorich MJ, Mckinnon RA, Mackenzie PI (2004) Predicting human drug glucuronidation parameters: application of in vitro and in silico modelling approaches. Annu Rev Pharmacol Toxicol 44(1):1\u201325","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"11","key":"321_CR5","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1021\/acs.jcim.6b00233","volume":"56","author":"JD Tyzack","year":"2016","unstructured":"Tyzack JD, Hunt PA, Segall MD (2016) Predicting regioselectivity and lability of cytochrome P450 metabolism using quantum mechanical simulations. J Chem Inf Model 56(11):2180\u20132193","journal-title":"J Chem Inf Model"},{"issue":"1","key":"321_CR6","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1208\/aapsj080112","volume":"8","author":"FP Guengerich","year":"2006","unstructured":"Guengerich FP (2006) Cytochrome P450s and other enzymes in drug metabolism and toxicity. AAPS J 8(1):101\u2013111","journal-title":"AAPS J"},{"key":"321_CR7","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1002\/wcms.1323","volume":"7","author":"VA Dixit","year":"2017","unstructured":"Dixit VA, Lal LA, Agrawal SR (2017) Recent advances in the prediction of non-CYP450-mediated drug metabolism. WIREs Comput Mol Sci 7:1323","journal-title":"WIREs Comput Mol Sci"},{"issue":"17","key":"321_CR8","doi-asserted-by":"crossref","first-page":"3174","DOI":"10.1093\/bioinformatics\/btz037","volume":"35","author":"L Olsen","year":"2019","unstructured":"Olsen L, Montefiori M, Tran KP, J\u00f8rgensen FS (2019) SMARTCyp 3.0: enhanced cytochrome P450 site-of-metabolism prediction server. Bioinformatics 35(17):3174\u20133175","journal-title":"Bioinformatics"},{"issue":"22","key":"321_CR9","doi-asserted-by":"crossref","first-page":"6970","DOI":"10.1021\/jm050529c","volume":"48","author":"G Cruciani","year":"2005","unstructured":"Cruciani G, Carosati E, BoeckB De, Ethirajulu K, Mackie C, Howe T, Vianello R (2005) MetaSite: understanding metabolism in human cytochromes from the perspective of the chemist. J Med Chem 48(22):6970\u20136979","journal-title":"J Med Chem"},{"issue":"4","key":"321_CR10","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1002\/cmdc.200800384","volume":"4","author":"M Hennemann","year":"2009","unstructured":"Hennemann M, Friedl A, Lobell M, Keldenich J, Hillisch A, Clark T, G\u00f6ller A (2009) CypScore: quantitative prediction of reactivity toward cytochromes P450 based on semiempirical molecular orbital theory. ChemMedChem 4(4):657\u2013669","journal-title":"ChemMedChem"},{"issue":"12","key":"321_CR11","doi-asserted-by":"crossref","first-page":"3373","DOI":"10.1021\/ci400518g","volume":"53","author":"J Zaretzki","year":"2013","unstructured":"Zaretzki J, Matlock M, Swamidass SJ (2013) XenoSite: accurately predicting CYP-mediated sites of metabolism with neural networks. J Chem Inf Model 53(12):3373\u20133383","journal-title":"J Chem Inf Model"},{"issue":"8","key":"321_CR12","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1021\/acs.jcim.7b00250","volume":"57","author":"M \u0160\u00edcho","year":"2017","unstructured":"\u0160\u00edcho M, de Bruyn KC, Stork C, Svozil D, Kirchmair J (2017) FAME 2: simple and effective machine learning model of cytochrome P450 regioselectivity. J Chem Inf Model 57(8):1832\u20131846","journal-title":"J Chem Inf Model"},{"issue":"2","key":"321_CR13","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/17425255.2017.1239718","volume":"13","author":"I Phillips","year":"2016","unstructured":"Phillips I, Shephard E (2016) Drug metabolism by flavin-containing monooxygenases of human and mouse. Expert Opin Drug Metab Toxicol 13(2):167\u2013181","journal-title":"Expert Opin Drug Metab Toxicol"},{"issue":"18","key":"321_CR14","doi-asserted-by":"crossref","first-page":"6572","DOI":"10.1073\/pnas.0800859105","volume":"105","author":"A Alfieri","year":"2008","unstructured":"Alfieri A, Malito E, Orru R, Fraaije M, Mattevi A (2008) Revealing the moonlighting role of NADP in the structure of a flavin-containing monooxygenase. Proc Natl Acad Sci 105(18):6572\u20136577","journal-title":"Proc Natl Acad Sci"},{"issue":"26","key":"321_CR15","doi-asserted-by":"crossref","first-page":"9832","DOI":"10.1073\/pnas.0602398103","volume":"103","author":"S Eswaramoorthy","year":"2006","unstructured":"Eswaramoorthy S, Bonanno J, Burley S, Swaminathan S (2006) Mechanism of action of a flavin-containing monooxygenase. Proc Natl Acad Sci 103(26):9832\u20139837","journal-title":"Proc Natl Acad Sci"},{"issue":"4","key":"321_CR16","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00008571-199708000-00001","volume":"7","author":"PI Mackenzie","year":"1997","unstructured":"Mackenzie PI, Owens IS, Burchell B, Bock KW, Bairoch A, B\u00e9langer A, Fournel-Gigleux S, Green M, Hum DW, Iyanagi T, Lancet D, Louisot P, Magdalou J, Chowdhury JR, Ritter JK, Schachter H, Tephly TR, Tipton KF, Nebert DW (1997) The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 7(4):255\u2013269","journal-title":"Pharmacogenetics"},{"issue":"3","key":"321_CR17","first-page":"335","volume":"47","author":"PC Nair","year":"2015","unstructured":"Nair PC, Meech R, Mackenzie PI, McKinnon RA, Miners JO (2015) Insights into the UDP-sugar selectivities of human UDP-glycosyltransferases (UGT): a molecular modelling perspective. Drug Metab Rev 47(3):335\u2013345","journal-title":"Drug Metab Rev"},{"key":"321_CR18","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bcp.2015.10.001","volume":"99","author":"KW Bock","year":"2016","unstructured":"Bock KW (2016) The UDP-glycosyltransferase (UGT) superfamily expressed in humans, insects and plants: animal\u2013plant arms-race and co-evolution. Biochem Pharmacol 99:11\u201317","journal-title":"Biochem Pharmacol"},{"issue":"52","key":"321_CR19","doi-asserted-by":"crossref","first-page":"36205","DOI":"10.1074\/jbc.M807961200","volume":"283","author":"P Mackenzie","year":"2008","unstructured":"Mackenzie P, Rogers A, Treloar J, Jorgensen BR, Miners JO, Meech R (2008) Identification of UDP Glycosyltransferase 3A1 as a UDP N-Acetylglucosaminyltransferase. J Biol Chem 283(52):36205\u201336210","journal-title":"J Biol Chem"},{"issue":"1","key":"321_CR20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1006\/geno.1996.0242","volume":"34","author":"A Bosio","year":"1996","unstructured":"Bosio A, Binczek E, Le Beau MM, Fernald AA, Stoffel W (1996) The human gene CGT encoding the UDP-galactose ceramide galactosyl transferase (cerebroside synthase): cloning, characterization, and assignment to human chromosome 4, band q26. Genomics 34(1):69\u201375","journal-title":"Genomics"},{"issue":"28","key":"321_CR21","doi-asserted-by":"crossref","first-page":"7385","DOI":"10.1021\/bi8006127","volume":"47","author":"R Banerjee","year":"2008","unstructured":"Banerjee R, Pennington MW, Garza A, Owens IS (2008) Mapping the UDP-glucuronic acid binding site in UDP-glucuronosyltransferase-1A10 by homology-based modelling: confirmation with biochemical evidence. Biochemistry 47(28):7385\u20137392","journal-title":"Biochemistry"},{"issue":"2","key":"321_CR22","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.jmb.2007.03.066","volume":"369","author":"MJ Miley","year":"2007","unstructured":"Miley MJ, Zielinska AK, Keenan JE, Bratton SM, Radominska-Pandya A, Redinbo MR (2007) Crystal structure of the cofactor-binding domain of the human phase II drug-metabolism enzyme UDP-glucuronosyltransferase 2B7. J Mol Biol 369(2):498\u2013511","journal-title":"J Mol Biol"},{"issue":"1","key":"321_CR23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1021\/tx500444e","volume":"28","author":"S Rendic","year":"2014","unstructured":"Rendic S, Guengerich FP (2014) Survey of human oxidoreductases and cytochrome P450 enzymes involved in the metabolism of xenobiotic and natural chemicals. Chem Res Toxicol 28(1):38\u201342","journal-title":"Chem Res Toxicol"},{"issue":"3","key":"321_CR24","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.pharmthera.2005.01.001","volume":"106","author":"SK Krueger","year":"2005","unstructured":"Krueger SK, Williams DE (2005) Mammalian flavin-containing monooxygenases: structure\/function, genetic polymorphisms and role in drug metabolism. Pharmacol Ther 106(3):357\u2013387","journal-title":"Pharmacol Ther"},{"issue":"1","key":"321_CR25","doi-asserted-by":"crossref","first-page":"e0169910","DOI":"10.1371\/journal.pone.0169910","volume":"12","author":"C-W Fu","year":"2017","unstructured":"Fu C-W, Lin T-H (2017) Predicting the metabolic sites by flavin-containing monooxygenase on drug molecules using SVM classification on computed quantum mechanics and circular fingerprints molecular descriptors. PLoS ONE 12(1):e0169910","journal-title":"PLoS ONE"},{"issue":"1","key":"321_CR26","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1021\/tx700079z","volume":"21","author":"FP Guengerich","year":"2008","unstructured":"Guengerich FP (2008) Cytochrome p450 and chemical toxicology. Chem Res Toxicol 21(1):70\u201383","journal-title":"Chem Res Toxicol"},{"issue":"11","key":"321_CR27","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1124\/dmd.104.000794","volume":"32","author":"JA Williams","year":"2004","unstructured":"Williams JA, Hyland R, Jones BC, Smith DA, Hurst S, Goosen TC, Peterkin V, Koup JR, Ball SE (2004) Drug-drug interactions for UDP-glucuronosyltransferase substrates: a pharmacokinetic explanation for typically observed low exposure (AUCi\/AUC) ratios. Drug Metab Dispos 32(11):1201\u20131208","journal-title":"Drug Metab Dispos"},{"issue":"6","key":"321_CR28","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1021\/ci600248e","volume":"46","author":"MJ Sorich","year":"2006","unstructured":"Sorich MJ, McKinnon RA, Miners JO, Smith PA (2006) The importance of local chemical structure for chemical metabolism by human uridine 5'-diphosphate\u2013glucuronosyltransferase. J Chem Inf Model 46(6):2692\u20132697","journal-title":"J Chem Inf Model"},{"issue":"20","key":"321_CR29","first-page":"1","volume":"32","author":"NL Dang","year":"2016","unstructured":"Dang NL, Hughes TB, Krishnamurthy V, Swamidass SJ (2016) A simple model predicts UGT-mediated metabolism. Bioinformatics 32(20):1\u20137","journal-title":"Bioinformatics"},{"issue":"4","key":"321_CR30","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1021\/acsmedchemlett.8b00603","volume":"10","author":"A Mazzolari","year":"2019","unstructured":"Mazzolari A, Afzal AM, Pedretti A, Testa B, Vistoli G, Bender A (2019) Prediction of UGT-mediated metabolism using the manually curated MetaQSAR database. ACS Med Chem Lett 10(4):633\u2013638","journal-title":"ACS Med Chem Lett"},{"issue":"4","key":"321_CR31","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1046\/j.1365-2125.2000.00265.x","volume":"50","author":"DH Lang","year":"2000","unstructured":"Lang DH, Rettie AE (2000) In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO): metabolism of benzydamine and caffeine by FMO and P450 isoforms. Br J Clin Pharmacol 50(4):311\u2013314","journal-title":"Br J Clin Pharmacol"},{"issue":"10","key":"321_CR32","first-page":"1231","volume":"28","author":"T Mushiroda","year":"2000","unstructured":"Mushiroda T, Douya R, Takahara E, Nagata O (2000) The involvement of flavin-containing monooxygenase but not CYP3A4 in metabolism of itopride hydrochloride, a gastroprokinetic agent: comparison with cisapride and mosapride citrate. Drug Metab Dispos 28(10):1231\u20131237","journal-title":"Drug Metab Dispos"},{"issue":"4","key":"321_CR33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1046\/j.1365-2125.2000.00170.x","volume":"49","author":"HC Rawden","year":"2000","unstructured":"Rawden HC, Kokwaro GO, Ward SA, Edwards G (2000) Relative contribution of cytochromes P-450 and flavin-containing monoxygenases to the metabolism of albendazole by human liver microsomes. Br J Clin Pharmacol 49(4):313\u2013322","journal-title":"Br J Clin Pharmacol"},{"issue":"1","key":"321_CR34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0009-2797(97)00055-0","volume":"106","author":"LH Overby","year":"1997","unstructured":"Overby LH, Carver GC, Philpot RM (1997) Quantitation and kinetic properties of hepatic microsomal and recombinant flavin-containing monooxygenases 3 and 5 from humans. Chem Biol Interact 106(1):29\u201345","journal-title":"Chem Biol Interact"},{"issue":"7","key":"321_CR35","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1002\/elps.200800604","volume":"30","author":"X Hai","year":"2009","unstructured":"Hai X, Adams E, Hoogmartens J, Van Schepdael A (2009) Enantioselective in-line and off-line CE methods for the kinetic study on cimetidine and its chiral metabolites with referenceto flavin-containing monooxygenase genetic isoforms. Electrophoresis 30(7):1248\u20131257","journal-title":"Electrophoresis"},{"issue":"4","key":"321_CR36","first-page":"587","volume":"21","author":"JR Cashman","year":"1993","unstructured":"Cashman JR, Park SB, Yang ZC (1993) Chemical, enzymatic, and human enantioselective S-oxygenation of cimetidine. Drug Metab Dispos 21(4):587\u2013597","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"321_CR37","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/0006-2952(87)90391-1","volume":"36","author":"KH Taylor","year":"1987","unstructured":"Taylor KH, Ziegler DM (1987) Studies on substrate specificity of the hog liver flavin-containingmonooxygenase: anionic organic sulfur compounds. Biochem Pharmacol 36(1):141\u2013146","journal-title":"Biochem Pharmacol"},{"issue":"1\u20133","key":"321_CR38","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.theochem.2005.05.023","volume":"757","author":"G Ottolina","year":"2005","unstructured":"Ottolina G, Gonzalo G, Carrea G (2005) Theoretical studies of oxygen atom transfer from flavin to electron-rich substrates. J Mol Struct (Thoechem) 757(1\u20133):175\u2013181","journal-title":"J Mol Struct (Thoechem)"},{"issue":"40","key":"321_CR39","doi-asserted-by":"crossref","first-page":"11087","DOI":"10.1021\/jp208087u","volume":"115","author":"R Bach","year":"2011","unstructured":"Bach R (2011) Role of the somersault rearrangement in the oxidation step for flavin monooxygenases (FMO). A comparison between FMO and conventional xenobiotic oxidation with hydroperoxides. J Phys Chem A 115(40):11087\u201311100","journal-title":"J Phys Chem A"},{"issue":"9","key":"321_CR40","first-page":"830","volume":"26","author":"EM Hawes","year":"1998","unstructured":"Hawes EM (1998) N+-Glucuronidation, a common pathway in human metabolism of drugs with a tertiary amine group: 1996 ASPET N-glucuronidation of xenobiotics symposium. Drug Metab Dispos 26(9):830\u2013837","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"321_CR41","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.abb.2006.07.010","volume":"454","author":"T Nishiyama","year":"2006","unstructured":"Nishiyama T, Kobori T, Arai K, Ogura K, Ohnuma T, Ishii K, Hayashi K, Hiratsuka A (2006) Identification of human UDP-glucuronosyltransferase isoform (s) responsible for the C-glucuronidation of phenylbutazone. Arch Biochem Biophys 454(1):72\u201379","journal-title":"Arch Biochem Biophys"},{"issue":"12","key":"321_CR42","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1515\/BC.2011.194","volume":"392","author":"D Buchheit","year":"2011","unstructured":"Buchheit D, Schmitt EI, Bischoff D, Ebner T, Bureik M (2011) S-Glucuronidation of 7-mercapto-4-methylcoumarin by human UDP glycosyltransferases in genetically engineered fission yeast cells. Biol Chem 392(12):1089\u20131095","journal-title":"Biol Chem"},{"issue":"2\u20133","key":"321_CR43","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.forsciint.2004.12.003","volume":"153","author":"RS Foti","year":"2005","unstructured":"Foti RS, Fisher MB (2005) Assessment of UDP-glucuronosyltransferase catalyzed formation of ethyl glucuronide in human liver microsomes and recombinant UGTs. Forensic Sci Int 153(2\u20133):109\u2013116","journal-title":"Forensic Sci Int"},{"issue":"2","key":"321_CR44","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1124\/dmd.105.005652","volume":"34","author":"GE Kuehl","year":"2006","unstructured":"Kuehl GE, Bigler J, Potter JD, Lampe JW (2006) Glucuronidation of the aspirin metabolite salicylic acid by expressed UDP-glucuronosyltransferases and human liver microsomes. Drug Metab Dispos 34(2):199\u2013202","journal-title":"Drug Metab Dispos"},{"issue":"11","key":"321_CR45","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1124\/dmd.31.11.1361","volume":"31","author":"GE Kuehl","year":"2003","unstructured":"Kuehl GE, Murphy SE (2003) N-glucuronidation of nicotine and cotinine by human liver microsomes and heterologously expressed UDP-glucuronosyltransferases. Drug Metab Dispos 31(11):1361\u20131368","journal-title":"Drug Metab Dispos"},{"issue":"12","key":"321_CR46","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1093\/carcin\/14.12.2637","volume":"14","author":"C-J Jin","year":"1993","unstructured":"Jin C-J, Miners JO, Burchell B, Mackenzie PI (1993) The glucuronidation of hydroxylated metabolites of benzo [\u03b1] pyrene and 2-acetylaminofluorene by cDNA-expressed human UDP-glucuronosyltransferases. Carcinogenesis 14(12):2637\u20132639","journal-title":"Carcinogenesis"},{"issue":"1","key":"321_CR47","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1042\/bj3030233","volume":"303","author":"SB Senafi","year":"1994","unstructured":"Senafi SB, Clarke DJ, Burchell B (1994) Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem J 303(1):233\u2013240","journal-title":"Biochem J"},{"issue":"1","key":"321_CR48","first-page":"475","volume":"264","author":"C Jin","year":"1993","unstructured":"Jin C, Miners JO, Lillywhite KJ, Mackenzie PI (1993) Complementary deoxyribonucleic acid cloning and expression of a human liver uridine diphosphate-glucuronosyltransferase glucuronidating carboxylic acid-containing drugs. J Pharmacol Exp Ther 264(1):475\u2013479","journal-title":"J Pharmacol Exp Ther"},{"key":"321_CR49","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.phrs.2017.05.001","volume":"121","author":"N Yang","year":"2017","unstructured":"Yang N, Sun R, Liao X, Aa J, Wang G (2017) UDP-glucuronosyltransferases (UGTs) and their related metabolic cross-talk with internal homeostasis: a systematic review of UGT isoforms for precision medicine. Pharmacol Res 121:169\u2013183","journal-title":"Pharmacol Res"},{"key":"321_CR50","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1146\/annurev.pharmtox.40.1.581","volume":"40","author":"RH Tukey","year":"2000","unstructured":"Tukey RH, Strassburg CP (2000) Human UDP-glucuronosyltransferases: metabolism, expression, and disease. Annu Rev Pharmacol Toxicol 40:581\u2013616","journal-title":"Annu Rev Pharmacol Toxicol"},{"issue":"69","key":"321_CR51","first-page":"1","volume":"7","author":"C Li","year":"2007","unstructured":"Li C, Wu Q (2007) Adaptive evolution of multiple-variable exons and structural diversity of drug-metabolizing enzymes. BMC Evol Biol 7(69):1\u201320","journal-title":"BMC Evol Biol"},{"key":"321_CR52","doi-asserted-by":"crossref","first-page":"17960","DOI":"10.1016\/S0021-9258(17)32403-1","volume":"269","author":"PJ Bosma","year":"1994","unstructured":"Bosma PJ, Seppen J, Goldhoorn B, Bakker C, Oude Elferink RP, Chowdhury JR, Chowdhury NR, Jansen PLM (1994) Bilirubin UDP-glucuronosyltransferase 1 is the only relevant bilirubin glucuronidating isoform in man. J Biol Chem 269:17960\u201317964","journal-title":"J Biol Chem"},{"key":"321_CR53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2016.00388","volume":"7","author":"R Fujiwara","year":"2016","unstructured":"Fujiwara R, Yokoi T, Nakajima M (2016) Structure and protein\u2013protein interactions of human UDP-glucuronosyltransferases. Front Pharmacol 7:1\u201315","journal-title":"Front Pharmacol"},{"key":"321_CR54","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1146\/annurev.biochem.76.061005.092322","volume":"77","author":"LL Lairson","year":"2008","unstructured":"Lairson LL, Henrissat B, Davies GJ, Withers SG (2008) Glycosyltransferases: structures, functions, and mechanisms. Annu Rev Biochem 77:521\u2013555","journal-title":"Annu Rev Biochem"},{"issue":"22","key":"321_CR55","doi-asserted-by":"crossref","first-page":"8350","DOI":"10.1039\/C5CS00600G","volume":"44","author":"D-M Liang","year":"2015","unstructured":"Liang D-M, Liu J-H, Wu H, Wang B-B, Zhu H-J, Qiao J-J (2015) Glycosyltransferases: mechanisms and applications in natural product development. Chem Soc Rev 44(22):8350\u20138374","journal-title":"Chem Soc Rev"},{"issue":"2","key":"321_CR56","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/00498250601129109","volume":"37","author":"CW Locuson","year":"2007","unstructured":"Locuson CW, Tracy TS (2007) Comparative modelling of the human UDP-glucuronosyltransferases: insights into structure and mechanism. Xenobiotica 37(2):155\u2013168","journal-title":"Xenobiotica"},{"issue":"6","key":"321_CR57","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1124\/mol.58.6.1609","volume":"58","author":"M Ouzzine","year":"2000","unstructured":"Ouzzine M, Antonio L, Burchell B, Netter P, Fournel-Gigleux S, Magdalou J (2000) Importance of histidine residues for the function of the human liver UDP-glucuronosyltransferase UGT1A6: evidence for the catalytic role of histidine 370. Mol Pharmacol 58(6):1609\u20131615","journal-title":"Mol Pharmacol"},{"key":"321_CR58","doi-asserted-by":"crossref","first-page":"36514","DOI":"10.1074\/jbc.M703107200","volume":"282","author":"D Li","year":"2007","unstructured":"Li D, Fournel-Gigleux S, Barr\u00e9 L, Mulliert G, Netter P, Magdalou J, Ouzzine M (2007) Identification of aspartic acid and histidine residues mediating the reaction mechanism and the substrate specificity of the human UDP-glucuronosyltransferases 1A. J Biol Chem 282:36514\u201336524","journal-title":"J Biol Chem"},{"issue":"4","key":"321_CR59","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1081\/DMR-100101944","volume":"31","author":"A Radominska-Pandya","year":"1999","unstructured":"Radominska-Pandya A, Czernik PJ, Little JM, Battaglia E, Mackenzie PI (1999) Structural and functional studies of UDP-glucuronosyltransferases. Drug Metab Rev 31(4):817\u2013899","journal-title":"Drug Metab Rev"},{"key":"321_CR60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1758-2946-4-17","volume":"4","author":"MD Hanwell","year":"2012","unstructured":"Hanwell MD, Curtis DE, Lonie DC, Vandermeersch T, Zurek E, Hutchison GR (2012) Avogadro: an advanced semantic chemical editor, visualization, and analysis platform. J Cheminf 4:1\u201317","journal-title":"J Cheminf"},{"issue":"7","key":"321_CR61","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1021\/cr00023a012","volume":"93","author":"J Sadowski","year":"1993","unstructured":"Sadowski J, Gasteiger J (1993) From atoms and bonds to three-dimensional atomic coordinates: automatic model builders. J Chem Rev 93(7):2567\u20132581","journal-title":"J Chem Rev"},{"issue":"13","key":"321_CR62","doi-asserted-by":"crossref","first-page":"3902","DOI":"10.1021\/ja00299a024","volume":"107","author":"MJS Dewar","year":"1985","unstructured":"Dewar MJS, Zoebisch EG, Healyand EF, Stewart JJP (1985) Development and use of quantum mechanical molecular models. 76. AM1: a new general purpose quantum mechanical molecular model. J Am Chem Soc 107(13):3902\u20133909","journal-title":"J Am Chem Soc"},{"key":"321_CR63","first-page":"86","volume":"10","author":"JJP Stewart","year":"1990","unstructured":"Stewart JJP (1990) MOPAC: a general molecular orbital package. Quant Chem Prog Exch 10:86","journal-title":"Quant Chem Prog Exch"},{"key":"321_CR64","doi-asserted-by":"crossref","first-page":"5648","DOI":"10.1063\/1.464913","volume":"98","author":"AD Becke","year":"1993","unstructured":"Becke AD (1993) Density-functional thermochemistry. III. The role of exact exchange. J Chem Phys 98:5648\u20135652","journal-title":"J Chem Phys"},{"key":"321_CR65","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1103\/PhysRevB.37.785","volume":"37","author":"C Lee","year":"1988","unstructured":"Lee C, Yang W, Parr RG (1988) Development of the Colle-Salvetti correlation-energy formula into a functional of the electron density. Phys Rev B 37:785\u2013789","journal-title":"Phys Rev B"},{"key":"321_CR66","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1139\/p80-159","volume":"58","author":"SH Vosko","year":"1980","unstructured":"Vosko SH, Wilk L, Nusair M (1980) Accurate spin-dependent electron liquid correlation energies for local spin density calculations: a critical analysis. Can J Phys 58:1200\u20131211","journal-title":"Can J Phys"},{"issue":"45","key":"321_CR67","doi-asserted-by":"crossref","first-page":"11623","DOI":"10.1021\/j100096a001","volume":"98","author":"PJ Stephens","year":"1994","unstructured":"Stephens PJ, Devlin FJ, Chabalowski CF, Frisch MJ (1994) Ab initio calculation of vibrational absorption and circular dichroism spectra using density functional force fields. J Phys Chem 98(45):11623\u201311627","journal-title":"J Phys Chem"},{"issue":"18","key":"321_CR68","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1039\/b508541a","volume":"7","author":"F Weigend","year":"2005","unstructured":"Weigend F, Ahlrichs R (2005) Balanced basis sets of split valence, triple zeta valence and quadruple zeta valence quality for H to Rn: design and assessment of accuracy. Phys Chem Chem Phys 7(18):3297\u20133305","journal-title":"Phys Chem Chem Phys"},{"issue":"3","key":"321_CR69","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1039\/C0OB00477D","volume":"9","author":"L Sim\u00f3n","year":"2011","unstructured":"Sim\u00f3n L, Goodman JM (2011) How reliable are DFT transition structures? Comparison of GGA, hybrid-meta-GGA and meta-GGA functionals. Org Biomol Chem 9(3):689\u2013700","journal-title":"Org Biomol Chem"},{"issue":"15","key":"321_CR70","doi-asserted-by":"crossref","first-page":"154104","DOI":"10.1063\/1.3382344","volume":"132","author":"S Grimme","year":"2010","unstructured":"Grimme S, Antony J, Ehrlich S, Krieg H (2010) A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu. J Chem Phys 132(15):154104\u2013154119","journal-title":"J Chem Phys"},{"issue":"9","key":"321_CR71","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1016\/j.cpc.2010.04.018","volume":"181","author":"M Valiev","year":"2010","unstructured":"Valiev M, Bylaska EJ, Govind N, Kowalski K, Straatsma TP, van Dam HJJ, Wang D, Nieplocha J, Apra E, Windus TL, de Jong WA (2010) NWChem: A comprehensive and scalable open-source solution for large scale molecular simulations. Comput Phys Commun 181(9):1477\u20131489","journal-title":"Comput Phys Commun"},{"key":"321_CR72","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/jcc.22885","volume":"33","author":"T Lu","year":"2012","unstructured":"Lu T, Chen F (2012) Multiwfn: a multifunctional wavefunction analyser. J Comput Chem 33:580\u2013592","journal-title":"J Comput Chem"},{"key":"321_CR73","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00549096","volume":"44","author":"FL Hirshfeld","year":"1977","unstructured":"Hirshfeld FL (1977) Bonded-atom fragments for describing molecular charge densities. Theor Chim Acta 44:129\u2013138","journal-title":"Theor Chim Acta"},{"issue":"2","key":"321_CR74","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.taap.2008.09.004","volume":"233","author":"C Leoni","year":"2008","unstructured":"Leoni C, Buratti F, Testai E (2008) The participation of human hepatic P450 isoforms, flavin-containing monooxygenases and aldehyde oxidase in the biotransformation of the insecticide fenthion. Toxicol Appl Pharmacol 233(2):343\u2013352","journal-title":"Toxicol Appl Pharmacol"},{"issue":"8","key":"321_CR75","first-page":"1003","volume":"28","author":"Y Kim","year":"2000","unstructured":"Kim Y, Ziegler D (2000) Size limits of thiocarbamides accepted as substrates by human flavin-containing monooxygenase 1. Drug Metab Dispos 28(8):1003\u20131006","journal-title":"Drug Metab Dispos"},{"key":"321_CR76","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1007\/s11095-011-0418-5","volume":"28","author":"B Wu","year":"2011","unstructured":"Wu B, Xu B, Hu M (2011) Regioselective glucuronidation of flavonols by six human UGT1A isoforms. Pharm Res 28:1905\u20131918","journal-title":"Pharm Res"},{"issue":"6","key":"321_CR77","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1021\/mp200300w","volume":"8","author":"B Wu","year":"2011","unstructured":"Wu B, Zhang S, Hu M (2011) Evaluation of 3,3\u2032,4\u2032-trihydroxyflavone and 3,6,4\u2032-trihydroxyflavone (4\u2032-O-glucuronidation) as the in vitro functional markers for hepatic UGT1A1. Mol Pharm 8(6):2379\u20132389","journal-title":"Mol Pharm"},{"issue":"4","key":"321_CR78","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1124\/mol.107.037952","volume":"72","author":"T Kubota","year":"2007","unstructured":"Kubota T, Lewis BC, Elliot DJ, Mackenzie PI, Miners JO (2007) Critical roles of residues 36 and 40 in the phenol and tertiary amine aglycone substrate selectivities of UDP-glucuronosyltransferases 1A3 and 1A4. Mol Pharmacol 72(4):1054\u20131062","journal-title":"Mol Pharmacol"},{"issue":"6","key":"321_CR79","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1124\/mol.109.063289","volume":"77","author":"L Laakkonen","year":"2010","unstructured":"Laakkonen L, Finel M (2010) A molecular model of the human UDP-glucuronosyltransferase 1A1, its membrane orientation, and the interactions between different parts of the enzyme. Mol Pharmacol 77(6):931\u2013939","journal-title":"Mol Pharmacol"},{"issue":"12","key":"321_CR80","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1021\/acs.chemrestox.5b00315","volume":"28","author":"T Lassila","year":"2015","unstructured":"Lassila T, Hokkanen J, Aatsinki S-M, Mattila S, Turpeinen M, Tolonen A (2015) Toxicity of carboxylic acid-containing drugs: the role of acyl migration and CoA conjugation investigated. Chem Res Toxicol 28(12):2292\u20132303","journal-title":"Chem Res Toxicol"},{"issue":"3","key":"321_CR81","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1021\/acs.molpharmaceut.7b00871","volume":"15","author":"R Juovonen","year":"2018","unstructured":"Juovonen R, Rauham\u00e4ki S, Kortet S, Niinivehmas S, Troberg J, Petsalo A, Huuskonen J, Raunio H, Finel M, Pentik\u00e4inen OT (2018) Molecular docking-based design and development of a highly selective probe substrate for UDP-glucuronosyltransferase 1A10. Mol Pharm 15(3):923\u2013933","journal-title":"Mol Pharm"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-020-00321-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10822-020-00321-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-020-00321-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,6,11]],"date-time":"2021-06-11T23:26:53Z","timestamp":1623454013000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10822-020-00321-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,6,12]]},"references-count":81,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["321"],"URL":"https:\/\/doi.org\/10.1007\/s10822-020-00321-1","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,6,12]]},"assertion":[{"value":"31 March 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 June 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 June 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"M\u00d6, PAH and MDS are employees of Optibrium Ltd. DJP is an employee of Lhasa Ltd. PJW was an employee of Optibrium Ltd. for the duration of the FMO project.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest"}},{"value":"The research does not involve human participation or personal data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}